Commercialisation news The latest commercialisation news from the University of Sheffield. Off Next wave of display technology set to be unlocked by University of Sheffield spinout Next-generation screen technology, capable of making smartwatch, PC and other consumer electronics’ displays more affordable and durable, is being pioneered by a University of Sheffield spin-out company. 10 July 2026 Sheffield and South Yorkshire tech ecosystem ranked as the number one rising star in the UK As part of the Dealroom 2026 Global Tech Ecosystem Index, Sheffield and South Yorkshire have been highlighted first in the UK for the category of Rising Stars. 1 June 2026 Biotech spinout MetalloBio raises £400k to tackle antibiotic resistance MetalloBio, a spinout company from the University of Sheffield, has successfully closed a pre-series A investment round raising over £400,000 to advance a new class of antimicrobial compounds designed to combat antibiotic resistance. 26 May 2026 Northern Gritstone co-leads £2 million pre-seed round into AmpliSi AmpliSi, a University of Sheffield spinout developing silicon anodes for next-generation lithium-ion batteries, has secured a £2 million pre-seed investment led by Northern Gritstone and Clean Growth Fund. 18 March 2026 New AI software set to accelerate delivery of vital Net-Zero infrastructure New software, developed by the University of Sheffield spin-out AENi and funded by the Grantham Centre for Sustainable Futures, aims to transform how the world’s essential net-zero infrastructure is planned. 17 February 2026 Advancing safer treatments in women’s pelvic health Stress urinary incontinence affects up to one in three women worldwide, but the most commonly used treatment has led to serious problems. Sheffield spinout, Audaxis Medical, is developing a new medical device that could be a safer option. 28 January 2026 Highlights and achievements from the 2025 Commercialisation Journey Celebrating the standout moments from this year’s Commercialisation Journey. 17 December 2025 Spinout spotlight: Kausalyze Kausalyze, a spinout from the University of Sheffield's School of Chemical, Materials and Biological Engineering, is providing systems-level intelligence to help process manufacturers reduce downtime and increase operational efficiency. 16 December 2025 Spinout spotlight: Mitotype Precision Labs Mitotype Precision Labs (MPL) is transforming how we screen drugs for neurodegenerative diseases. Their novel platform identifies treatments capable of restoring mitochondrial function, paving the way for disease-modifying therapies. 24 November 2025 Spinout spotlight: SilViA Bio SilViA Bio, a biotechnology spinout from the University of Sheffield's School of Chemical, Materials and Biological Engineering, is helping to make biomanufacturing faster, cheaper, and more reliable. 13 November 2025 Sheffield spinouts take centre stage at London Stock Exchange Trade Mission The recent Trade Mission to the London Stock Exchange provided an opportunity to showcase the region's fast-growing digital and advanced manufacturing sectors, as well as the talented startup businesses that have spun out from the University. 10 November 2025 Crucible Therapeutics appoints new Chief Executive Officer Crucible Therapeutics, a University of Sheffield spinout developing novel therapies for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, has announced the appointment of Dr Cliff Holloway as its Chief Executive Officer. 28 October 2025 Triple triumph: Sheffield spinouts shine at 2025 Business Awards Two spinout companies from the University's School of Electrical and Electronic Engineering achieved a triple triumph at this year's Sheffield Business awards, collectively taking home three awards. 20 October 2025 AMRC FerretWorks programme: Turning bold ideas into breakthrough innovations The AMRC FerretWorks: Startup programme is supporting early-stage entrepreneurs in the South Yorkshire region by bringing the centre's world-class resources to those with bold ideas and the ambition to scale. 26 September 2025 The Northern Triangle Talent Project: One year on The Northern Triangle Talent (NTT) project, a collaboration between Sheffield, Leeds, and Manchester universities, is powering northern spinouts by building a strong, globally-focused mentor community. 21 July 2025 First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved Rinri Therapeutics, a world leading spinout company from the University of Sheffield dedicated to transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, has received approval to begin its first-in-human clinical trial. 1 July 2025 AI-driven spinout set to transform advanced manufacturing Yorkshire AI Labs, in partnership with Dr Rob Ward and the University of Sheffield’s Advanced Manufacturing Research Centre (AMRC), has launched DigitalCNC, an AI-driven precision manufacturing software company. 17 June 2025 University Spinouts: The Sheffield Difference Sheffield is creating a strong future for University spinouts. With our growing investor network, improving infrastructure and rich talent pool, we are laying the foundations for the next generation of research-driven innovators to thrive. 11 April 2025 Crucible Therapeutics awarded £2.3 million to develop breakthrough therapies that address underlying causes of MND Crucible Therapeutics, a biotechnology spinout company, and University of Sheffield secure a £2.3 million Innovate UK Biomedical Catalyst award to develop breakthrough siRNA therapies that address underlying causes of Motor Neuron Disease (MND). 4 July 2025 Geoptic awarded prestigious King’s Award for Enterprise in Innovation Geoptic has been awarded a King’s Award for Enterprise in the Innovation category — considered the highest official honours for UK businesses. 7 May 2025 FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP) The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47). 6 May 2025 Leading investors back Northern Gritstone with new £50 million fundraise Northern Gritstone has announced its latest fundraise of £50 million from leading institutional investors bringing its total permanent capital to £362 million. 7 May 2025 Sheffield spinout takes major step towards advancing pioneering treatments for Hereditary Spastic Paraplegia (HSP) BlackfinBio Limited is a spinout company from the University of Sheffield set to pioneer novel therapies for rare genetic neurological diseases. 18 March 2025 University of Sheffield spinout company receives £4 million investment to unleash full potential of robotics A University of Sheffield spinout company that is set to help developers overcome the cost and complexity of programming robots, has secured £4 million in funding. 28 January 2025 University of Sheffield spinout secures £4m in seed funding round - technology set to support health-related research A University of Sheffield spinout that has developed a single-molecule detection platform to support health research has raised £4m in funding. 27 November 2024 City centre labs to drive innovation and start-up success In a move set to propel innovation and growth of early-stage companies, Sheffield Technology Parks (STP) and University of Sheffield are teaming up to build new lab spaces in the city centre. 15 August 2024 New ‘Tasty Spoon’™ will enhance food flavours for people living with dementia A spoon, designed to enhance the flavour of food for dementia patients experiencing a loss of taste, could help combat high levels of malnutrition. 26 July 2024 Northern universities launch spinout mentor network to empower entrepreneurs The universities of Sheffield, Leeds, and Manchester are proud to announce the launch of the Northern Triangle Mentor Network, a dynamic initiative designed to propel commercialisation opportunities and empower early-stage spinouts. 25 June 2024 New company Midland Pharmaceuticals launched to develop therapeutics for stroke and spinal cord injury Researchers from the University of Sheffield and the University of Birmingham have joined forces with NLC Health Ventures to co-found a company developing new treatments for spinal cord injuries and stroke. 30 May 2024 Sheffield spinout company grows to lead on next generation biomedicines and bioprocesses SynGenSys, a fast-growing biotechnology company spun out of the University of Sheffield, has announced the appointment of Dr. Andy Racher as its Commercial Operations Director. 1 May 2024 World leading expert on bio-inspired AI to direct University of Sheffield’s Centre for Machine Intelligence One of the world’s leading innovators in bio-inspired AI has joined the University of Sheffield, as part of a new multi-million pound centre that is set to transform the institution’s research, innovation and teaching around artificial intelligence. 22 April 2024 Phlux technology clinches major export deal, revolutionising infrared sensing AI tech firm partners with AMRC Northern Triangle Talent Project secures £1.5m funding to strengthen regional commercialisation activity The Northern Triangle Talent Project has secured funding to strengthen the regional technology commercialisation ecosystem and attract top talent to the north of England. 19 March 2024 University of Sheffield spinout company to pioneer novel therapies for genetic neurological diseases BlackfinBio has raised £2.75 million seed investment to advance revolutionary treatments for Hereditary Spastic Paraplegia (HSP). 11 December 2023 The University of Sheffield's response to the independent review of university spin-out companies The University of Sheffield welcomes the announcement of £20m to help universities develop more spinout companies made in the autumn statement, as well as the independent review of spin-out companies. 22 November 2023 World’s first low-energy bioplastics developed with the University of Sheffield raises £2 million investment The world’s first low-energy, non-oil-based, high-performance bioplastic, developed by Floreon with the University of Sheffield, has secured £2 million financing from Northern Gritstone. 21 November 2023 University of Sheffield spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases University of Sheffield spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone. 25 September 2023 Investment zones are the key to taking our potential towards prosperity Professor Koen Lamberts, President and Vice-Chancellor of the University of Sheffield, discusses how the new South Yorkshire Investment Zone can turn Yorkshire's potential into prosperity. 24 July 2023 Saving lives globally through entrepreneurship: Kirsty Smitten is named as FSB Entrepreneur of the Year 2023 Unlocking the human inner ear for new therapies to improve hearing loss and deafness An international team of scientists and surgeon has discovered a secure clinical pathway to the inner ear, which will enable the application of a range of regenerative therapies to restore hearing. 8 November 2022 Northern Gritstone lands first deal with OpteranSpin-out company secures funding for device that ‘could revolutionise biology research’ Sheffield businesses first to receive millions from new Northern investment company Northern Gritstone, an investment company founded by the universities of Sheffield, Leeds and Manchester with initial support from Research England, has allocated its first two investments to Sheffield-based businesses. 29 July 2022 Northern Gritstone secures first close of £215 million ahead of making its first investments A new investment company founded by the universities of Sheffield, Leeds and Manchester to help boost the commercialisation of university spinouts and start-ups in the north of England has today (20 May 2022) announced a first close of £215 million. 20 May 2022 Rinri Therapeutics raises £10 million to advance stem cell therapy for hearing loss University of Sheffield spinout company, Rinri Therapeutics, has raised a total of £10 million from investors and the UK Future Fund to advance its novel stem cell therapy to restore hearing loss. 21 April 2021 Sheffield spin-out set up to facilitate life-science discoveries Understanding how molecules interact within the body is essential in supporting the development of treatments and therapies. Exciting Instruments, a University of Sheffield spin-out company, is breaking down barriers for researchers in this field. 4 November 2021 Northern Gritstone announces leadership team Northern Gritstone, a new investment company founded by the Universities of Leeds, Manchester and Sheffield, has appointed Lord Jim O’Neill as Non-Executive Chairman and Duncan Johnson as CEO. 8 July 2021 Northern universities launch new investment company The universities of Sheffield, Leeds and Manchester are launching a new investment company to help boost the commercialisation of university spinouts and start-ups in the North of England. 25 April 2021